Lyell Immunopharma (LYEL) Investor Presentation - Slideshow

DRAFT JPM22 Updated 12-14-21 Lyell Immunopharma August 4, 2022 Forward Looking Statements Certain matters discussed in this presentation are "forward-looking statements" of Lyell Immunopharma, Inc, Inc. (hereinafter referred to as the "Company," "we," "us," or "our") within the meaning of the Private Securities Litigation Reform Act of 1995 (the "PSLRA"). All such written or oral statements made in this presentation, other than statements of historical fact, are forward-looking statements and are intended t ...